NEW YORK , April 14, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Sana Biotechnology, Inc. ("Sana" or the "Company") (NASDAQ: SANA) and certain officers. The class action, filed in the United States District Court for the Western District of Washington, and docketed under 25-cv-00512, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Sana securities between March 17, 2023 and November 4, 2024, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities …

WARREN, N.J., April 14, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announces CEO Dr. Ryan Saadi, MD, MPH, will participate in BioNJ's Fifteenth Annual Bio Partnering Conference. Dr. Saadi will be featured on the panel discussion titled Paths to Liquidity: Strategies for Adapting to a Volatile Market, moderated by David C Schwartz, Partner at Morgan Lewis. Along with Dr. Ryan Saadi, the panel will also include commentary from Matt Vamvakis, MBA, Managing Director, J.P. Morgan Private Bank, Amanda Laskey, Life Sciences Senior Analyst, RSM US, and Kee Colon, MBA, Managing Director, Cantor Fitzgerald.

Mobile broadband and fixed wireless access solutions provider Inseego reported Q4/2024 results ahead of muted expectations. However, management provided a disappointing outlook for Q1/2025 as key customers are winding down product promotions while others are dealing with elevated inventory levels. On the conference call, management perplexed analysts with ambitious full-year sales targets, which would have likely been a stretch even without the recent tariff issues.

Supercars Lead Group of Sought-After Modern Open-Top Porsches on Offer | Complete Digital Catalog for April 26 Auction Now Available Supercars Lead Group of Sought-After Modern Open-Top Porsches on Offer | Complete Digital Catalog for April 26 Auction Now Available

Procter & Gamble, Merck, Medtronic, Johnson & Johnson, Intuit, and Comcast have lagged behind the market's rebound, but they look set to rise from here.

Nvidia Corporation's fundamentals and technicals line up for a long trade.'s recent sell-off presents a buying opportunity, with fundamentals and technicals supporting a potential rally towards $300 by 2025. Market volatility and overextended positioning contributed to NVIDIA's decline, but the stock has shown signs of a bottom and strong reversal. Technical analysis suggests limited downside risk, with strong support around $65 and potential for significant upside if key levels are cleared.

Blackstone's diversified private markets platform and leading position in the industry make it a compelling buy, especially given the current attractive valuation and 4.5% dividend yield. The firm's fee-earning AUM provides a stable revenue floor, ensuring dependable earnings even during market downturns, with significant growth potential in the private wealth channel. Despite recent market challenges, Blackstone's historical performance outpaces the S&P 500, making it a proven winner with a strong track record of delivering attractive returns.

Catalyst anchor Madison Mills reports on the latest market movers for April 14, 2025. Stocks move into the green with tech and financials as the top two performing sectors.

GRAND RAPIDS, Mich.--(BUSINESS WIRE)--UFP Industries (Nasdaq: UFPI) will announce first quarter 2025 results on Monday, April 28, 2025. The company will host a conference call to discuss these results on Tuesday, April 29, 2025, at 9 a.m. Eastern Time. A live audio webcast of the call along with supporting materials will be available on the UFP Industries Investor Relations website at www.ufpinvestor.com/news-filings-reports#events---presentations. A webcast replay will be available on the comp.

NEW YORK , April 14, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against e.l.f. Beauty, Inc. ("Elf" or the "Company") (NYSE: ELF) and certain officers.

Brookfield Corporation's common shares are complex and potentially overvalued. We see the real estate arm as hopelessly over-leveraged and overvalued with a 15X debt to EBITDA ratio. Fitch Ratings affirmed Brookfield's 'A-' ratings still make sense because of the firewalls in place.

Progressive (PGR) could produce exceptional returns because of its solid growth attributes.

Broadcom Inc. (AVGO) possesses solid growth attributes, which could help it handily outperform the market.

Heico (HEI) could produce exceptional returns because of its solid growth attributes.

NEW YORK, NY / ACCESS Newswire / April 14, 2025 / If you suffered a loss on your Alarum Technologies Ltd. (NASDAQ:ALAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/alarum-technologies-ltd-lawsuit-submission-form?prid=142981&wire=1 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / April 14, 2025 / If you suffered a loss on your Elastic N.V. (NYSE:ESTC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/elastic-n-v-lawsuit-submission-form?prid=142982&wire=1 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / April 14, 2025 / If you suffered a loss on your enCore Energy Corp. (NASDAQ:EU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/encore-energy-corp-lawsuit-submission-form?prid=142983&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / April 14, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/actinium-lawsuit-submission-form?prid=142984&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / April 14, 2025 / If you suffered a loss on your Fluence Energy, Inc. (NASDAQ:FLNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fluence-energy-lawsuit-submission-form?prid=142985&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / April 14, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of The Bancorp, Inc. (NASDAQ:TBBK) between January 25, 2024 and March 4, 2025, both dates inclusive (the "Class Period"), of the important May 16, 2025 lead plaintiff deadline. SO WHAT: If you purchased Bancorp securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.